Tenon Medical Future Growth

Future criteria checks 2/6

Tenon Medical is forecast to grow earnings and revenue by 3.6% and 60.2% per annum respectively while EPS is expected to grow by 39.4% per annum.

Key information

3.6%

Earnings growth rate

39.4%

EPS growth rate

Medical Equipment earnings growth16.7%
Revenue growth rate60.2%
Future return on equityn/a
Analyst coverage

Low

Last updated03 Jun 2024

Recent future growth updates

Recent updates

We're A Little Worried About Tenon Medical's (NASDAQ:TNON) Cash Burn Rate

Nov 29
We're A Little Worried About Tenon Medical's (NASDAQ:TNON) Cash Burn Rate

Is Tenon Medical (NASDAQ:TNON) In A Good Position To Invest In Growth?

Aug 15
Is Tenon Medical (NASDAQ:TNON) In A Good Position To Invest In Growth?

Earnings and Revenue Growth Forecasts

NasdaqCM:TNON - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20259-13N/A-112
12/31/20245-15N/A-102
3/31/20243-14-11-11N/A
12/31/20233-16-13-12N/A
9/30/20232-20-14-13N/A
6/30/20232-20-14-14N/A
3/31/20231-21-14-13N/A
12/31/20221-19-13-12N/A
9/30/20220-14-11-10N/A
6/30/20220-13-9-8N/A
3/31/20220-9-7-7N/A
12/31/20210-7-4-4N/A
9/30/20210-4-3-3N/A
6/30/20210-2-1-1N/A
3/31/20210-100N/A
12/31/20200-100N/A
12/31/20190-100N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TNON is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TNON is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TNON is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TNON's revenue (60.2% per year) is forecast to grow faster than the US market (8.6% per year).

High Growth Revenue: TNON's revenue (60.2% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TNON's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.